Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples